Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
8.10
+0.15 (1.89%)
At close: Dec 20, 2024, 4:00 PM
7.78
-0.32 (-4.01%)
After-hours: Dec 20, 2024, 7:17 PM EST
Ensysce Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 4.42 | 2.23 | 2.52 | 3.53 | 3.93 | 1.76 |
| Revenue Growth (YoY) | 40.41% | -11.61% | -28.54% | -10.18% | 122.86% | - |
| Cost of Revenue | 5.65 | 7.59 | 19.84 | 4.69 | 4.39 | 3.4 |
| Gross Profit | -1.23 | -5.36 | -17.31 | -1.16 | -0.46 | -1.64 |
| Selling, General & Admin | 5.08 | 5.36 | 6.91 | 18.71 | 1.15 | 6.93 |
| Operating Expenses | 5.08 | 5.36 | 6.91 | 18.71 | 1.15 | 6.93 |
| Operating Income | -6.31 | -10.72 | -24.22 | -19.87 | -1.61 | -8.57 |
| Interest Expense | -1.62 | -0.35 | -1.25 | -3.22 | -1 | -0.96 |
| Other Non Operating Income (Expenses) | 0.01 | 0.3 | -0.53 | -2.91 | 2.45 | -0.58 |
| EBT Excluding Unusual Items | -7.93 | -10.77 | -26 | -26 | -0.16 | -10.1 |
| Other Unusual Items | - | 0.15 | 1.79 | -3.15 | - | - |
| Pretax Income | -7.93 | -10.63 | -24.21 | -29.15 | -0.16 | -10.1 |
| Earnings From Continuing Operations | -7.93 | -10.63 | -24.21 | -29.15 | -0.16 | -10.1 |
| Minority Interest in Earnings | 0 | 0.01 | 0.04 | 0.06 | 0.22 | - |
| Net Income | -7.93 | -10.61 | -24.17 | -29.08 | 0.06 | -10.1 |
| Preferred Dividends & Other Adjustments | 0 | 0.01 | 0.91 | 0.8 | - | - |
| Net Income to Common | -7.93 | -10.63 | -25.09 | -29.89 | 0.06 | -10.1 |
| Shares Outstanding (Basic) | 0 | 0 | 0 | - | - | 0 |
| Shares Outstanding (Diluted) | 0 | 0 | 0 | - | - | 0 |
| Shares Change (YoY) | 285.29% | 1158.33% | - | - | - | - |
| EPS (Basic) | -18.32 | -70.40 | -2091.33 | - | - | -151.87 |
| EPS (Diluted) | -18.32 | -70.40 | -2091.33 | - | - | -151.87 |
| Free Cash Flow | -8.54 | -10.78 | -17.89 | -8.24 | -1.25 | -0.94 |
| Free Cash Flow Per Share | -19.73 | -71.42 | -1491.24 | - | - | -14.06 |
| Gross Margin | -27.78% | -240.17% | - | -32.82% | -11.66% | -92.88% |
| Operating Margin | -142.70% | -480.52% | -959.91% | -562.71% | -41.04% | -485.74% |
| Profit Margin | -179.29% | -476.39% | -994.12% | -846.37% | 1.44% | -572.70% |
| Free Cash Flow Margin | -193.16% | -483.29% | -708.87% | -233.41% | -31.73% | -53.02% |
| EBITDA | - | - | -24.22 | -19.87 | -1.61 | -8.57 |
| EBITDA Margin | - | - | - | - | -41.03% | - |
| D&A For EBITDA | - | - | 0 | 0 | 0 | 0 |
| EBIT | -6.31 | -10.72 | -24.22 | -19.87 | -1.61 | -8.57 |
| EBIT Margin | -142.70% | - | - | - | -41.04% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.